BYOOVIZ, approved by the FDA in September 2021 as the first ophthalmology biosimilar in the US, has been commercially available since June 2022 Samsung Bioepis
The Dr. Michael Lebow Scholarship for Future Doctors is now officially open for applications, inviting undergraduate students across the United States to compete for a one-time academic
USD 50 billion commitment includes new state-of-the art research and development (R&D) sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California and
Partnership Reduces Costs and Demands Placed Upon the Healthcare System Sensitek, a Cellhub company based in Hicksville, NY, announced a strategic partnership with GRTHealth, a
